• Projected Earnings Forecast: cbdMD (NYSE American: YCBD) anticipates an EPS of -$0.45 for the upcoming quarter, marking a potential decline from the prior quarter’s EPS of -$0.15.
• Revenue Insights: The imminent revenue forecast hovers around $4.81 million, a slight decrease from $5.17 million reported previously.
• Financial Stability Focus: Despite projected revenue adjustments, cbdMD concludes the fiscal year with an improved cash position, reducing its net loss substantially by $19.1 million compared to last year.

cbdMD, Inc. continues to be a key player in the CBD market with a diverse product offering. As the company prepares for its earnings release scheduled for December 20, 2024, the market watches closely as these financial results may reflect the broader health of the CBD industry.

Amidst evolving market conditions, cbdMD’s gross profit remained steady at approximately $3.40 million, while its EBITDA reflects a push towards financial recovery despite challenges faced.